Article

Comparing mutational pathways to lopinavir resistance in HIV-1 subtypes B versus C

2020-09-25

Abstract excerpt

Although combination antiretoviral therapies seem to be effective at controlling HIV-1 infections regardless of the viral subtype, there is increasing evidence for subtype-specific drug resistance mutations. The order and rates at which resistance mutations accumulate in different subtypes also remain poorly understood. Here, we present a methodology for the comparison of mutational pathways in different HIV-1 sub...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: a3d46b26-ccec-5abd-a3ad-04bf8ee6abef
DOI: 10.1101/2020.09.25.312942

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Comparing mutational pathways to lopinavir resistance in HIV-1 subtypes B versus CDOI 10.1101/2020.09.25.312942Read

Comparing mutational pathways to lopinavir resistance in HIV-1 subtypes B versus C.Semantic proximity Read

Discovering human immunodeficiency virus mutational pathways using temporal Bayesian networks.Semantic proximity Read

A phylogenetic and Markov model approach for the reconstruction of mutational pathways of drug resistance.Semantic proximity Read

Forecasting drug resistant HIV protease evolutionSemantic proximity Read

Global Comparison of Drug Resistance Mutations After First-Line Antiretroviral Therapy Across Human Immunodeficiency Virus-1 SubtypesSemantic proximity Read

A Bayesian network approach to study host and viral genetic correlates of HIV-1 disease progressionSemantic proximity Read

Transmission networks of drug resistance acquired in primary/early stage HIV infection.Semantic proximity Read

In Vivo Emergence of a Novel Protease Inhibitor Resistance Signature in HIV-1 Matrix.Semantic proximity Read

Phylogenetic Network Analyses Reveal the Influence of Transmission Clustering on the Spread of HIV Drug Resistance in Quebec from 2002 to 2022.Semantic proximity Read

In Vivo Emergence of a Novel Protease Inhibitor Resistance Signature in HIV-1 MatrixSemantic proximity Read

Modeling Drug Resistance Emergence and Transmission in HIV-1 in the UK.Semantic proximity Read

Bayesian analysis of complex interacting mutations in HIV drug resistance and cross-resistance.Semantic proximity Read